Background: The difference in restricted mean survival time (rmstD t ð Þ), the area between two survival curves up to time horizon t , is often used in cost-effectiveness analyses to estimate the treatment effect in randomized controlled trials. A challenge in individual patient data (IPD) meta-analyses is to account for the trial effect. We aimed at comparing different methods to estimate the ...
